Collectively, these studies demonstrate that SIRT6 acts as a protective regulator in both peripheral adipose tissue and central hypothalamic microglia, highlighting its potential as a therapeutic target for obesity and obesity-related metabolic dysfunction. Here, SIRT6 is linked to obesity due to melanocortin 4 receptor deficiency.